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A bstract
Background: laminectomy is a valuable surgical treatment for some patients with a cervical 
radiculomyelopathy due to cervical spinal stenosis. More recently attention has been given to 
motion of the spinal cord over spondylotic spurs as a cause of myelopathic changes. Immobilisation 
by fusion could have a positive effect on the recovery of myelopathic signs or changes. This has 
never been investigated in a prospective, randomised trial. Lamifuse is an acronyme for 
laminectomy and fusion.
M ethods/Design: Lamifuse is a multicentre, randomised controlled trial comparing laminectomy 
with and without fusion in patients with a symptomatic cervical canal stenosis. The study population 
will be enrolled from patients that are 60 years or older with myelopathic signs and/or symptoms 
due to a cervical canal stenosis. A  kyphotis shape of the cervical spine is an exclusion criterium. 
Each treatment arm needs 30 patients.
Discussion : This study will contribute to the discussion whether additional fusion after a cervical 
laminectomy results in a better clinical outcome.
IS R C T  num ber: ISRCTN72800446
Background
Cervical spondylosis is a progressive degenerative disease 
of the spine. As people grow older, the prevalence of cer­
vical spondylosis increases. It is a natural process of aging. 
Cervical spondylosis is seen in 10% of individuals in the 
age of 25 years, whereas in 95% of the persons of 65 years
[1].
Due to the degenerative process reduction of height of the 
intervertebral discs, formation of spondylophytes and
sometimes instability occurs. This may lead to a stenosis 
of the cervical spinal canal. In most instances it will 
remain asymptomatic. However, in some persons the ste­
nosis of the spinal canal leads to a compression of the spi­
nal cord. It is important to realize that not only static 
compression leads to neurological symptoms, but also 
dynamic factors do. In a normal situation the spinal cord 
will move during flexion and extension. Ventral osteo­
phytes in the spinal canal prevent up -  and downward 
movement [1]. Furthermore, the spinal cord is more
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stretched over the anterior bars increasing axial tension 
within the spinal cord. These forces are multidirectional 
creating secondary shearing forces resulting in stretch and 
shear injury to myelin and neural elements [2-4].
Patients may present with a diversity of well known signs 
and symptoms with variable intensities. Disturbance of 
the sensibility in the arms, clumsiness of the hands and 
problems with micturation may occur. However, the hall­
mark symptoms are gait abnormalities, weakness of the 
legs or stiffness of the legs [1,5].
The natural course of the cervical myelopathy is variable. 
But patients developing mild or moderate symptoms are 
less likely to improve spontaneously. Non operative treat­
ment will mainly affect neck pain or accompanying radic­
ulopathy. Improvement has been noted but is variable 
[6,7]. Patients with myelopathic signs and symptoms will, 
however, likely benefit from surgery [5,7,8].
Surgical approaches for cervical myelopathy due to cervi­
cal spondylosis can be anterior, posterior or combined. 
The last option is reserved for deformity correction. In 
most instances a lordotic or slight kyphotic cervical spine 
is present. The choice for an anterior or posterior 
approach is dependent on the main site of compression, 
the shape of the cervical sagittal curvature and to a lesser 
account on the preference of the surgeon.
Dorsal approaches are laminectomy or laminoplasty. A 
difference in clinical outcome has never been established. 
Prevention of post -  laminectomy kyphosis is a reason for 
laminoplasty. If an additional, instrumented dorsal 
fusion is performed, the change of developing a post-sur­
gical kyphosis is nearly zero[9]. It should be memorized 
that spondylotic processes also generate reduced motion 
of the spinal segments, a natural course [1]. From this 
point of view, decompression with fusion will have better 
clinical results when compared to decompression solely. 
In literature, indications in this direction are found. Fre­
quently used dorsal fusion techniques today use lateral 
mass screws and cervical pedicle screws. This is relatively 
safe with a minimal persistent complication rate. Further­
more, in experienced hands these techniques do not add 
substantial time to the duration of the surgery [7,9].
Despite a long-lasting interest in the various techniques, 
the clinical superiority of one method over the other has 
never been established. To our knowledge, a randomized 
controlled trial comparing laminectomy with or without 
fusion has never been performed.
Methods/Design
Hypothesis
Patients that are surgically treated for signs and symptoms 
due to a stenosis of the cervical spinal canal have a better 
clinical outcome when a dorsal fusion is performed in 
addition to a laminectomy compared to those that have 
solely a laminectomy.
At the end of the study, the quality of life, complications, 
and the costs will be evaluated comparing these two treat­
ment groups.
In -  and exclusion criteria
Patients with a minimal age of 60 years are included 
(Table 1). At neurologic examination myelopathic 
changes must be apparent. At magnetic resonance imag­
ing, concordant stenotic alterations at the cervical level(s) 
must be present. At the plain sitting lateral radiograph a 
lordotic spine must be shown. The shape of the cervical 
spine is lordotic when the vertebral bodies of C3 to C6 are 
in front of a line drawn from a point of the posterior infe­
rior part of the vertebral body of C2 to a point at the pos­
terior superior part of the vertebral body of C7 (Figure 1).
Only patients that sign the informed consent after some 
time of reflection (1 week) are included.
Clinical evaluation and follow up
At the first intake, duration of symptoms, other diseases, 
severity of signs and symptoms are noted. Neurologic 
examination is performed by an independent neurologist. 
At follow up, the severity of signs and symptoms are also 
noted. Special attention is given to the myelopathic
F ig u re !
Line from the posterior inferior part of the vertebral body of 
C2 to the posterior superior part o f the vertebral body of 
C7 in case of a normal cervical lordotic curvature (A) and a 
kyphotic cervical curve (B).
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Table 1: in - and exclusioncriteria
Inclusion
60 years or older
Cervical myelopathic 
symptoms and or signs at 
neurologic examination 
Stenosis of cervical spinal canal 
at MRI
Lordotic shape at lateral 
cervical plain radiograph, or at 




Previous cervical surgery for 
myelopathic signs and symptoms 
Solely radiculopathy, or most 
important complaint
Unable to undergo MRI
Life expectancy less than 2 years
Other diseases interfering with 
neurologic symptoms and signs, for 
example spinal cord glioma, thoracic 
herniated disc with spinal cord 
compression, multiple sclerosis etc. 
Rheumatoid arthritis 
Trauma to the neck in history 
Diseases interfering with 
rehabilitation, for example severe 
cardiac congestive disease. 
Participation in another study
changes in arms and/or legs. Furthermore, the clinical sit­
uation is evaluated by the modified Japanese Orthopaedic 
Association functional score[10] translated into the Dutch 
language. The validation of the Dutch translation is cur­
rently subject of investigation. Finally, a change in the 
quality of life is evaluated by the Dutch Short Form -  36 
Health Survey.
Follow -  up will be at six weeks, six months, and after one 
year postoperatively (Table 2). Complications are noted 
for their nature, duration and severity
Surgical technique
Cervical laminectomy of the compressed levels is per­
formed. Previous to the laminectomy a dorsal fusion is 
done. Dorsal fusion includes lateral mass screws from C2 
to C6. In C2, C7 and the upper thoracic spine levels, pedi­
cle screws will be placed. The screws are connected by rods 
or plates. Transverse connectors are used when indicated. 
In order to keep the posterior tension band intact, the 
fusion will extend from one level above the planned most
cranial laminectomy level to at least one level below the 
most caudal planned laminectomy site. If the lowest level 
of fusion would include C7 or lower extension of the 
fusion to the upper thoracic spine (Th2 or Th3) is recom- 
mended[11]. This extension of the fusion is thought to 
prevent junction disease at the cervicothoracic junction. 
For example, if the laminectomy includes the levels C4 to 
C6, the fusion would be from C3 to C7. Because C7 is the 
lowest fusion level, incorporation of Th1 is recom­
mended.
Surgical demands
Since fusion is added, only centres with a known spinal 
surgical experience are asked to participate. The surgeons 
performing a laminectomy should also be experienced in 
lateral mass fixation techniques, especially lateral mass 
and cervical pedicle screws.
Study Sites
The following centres will paricipate: Radboud University 
Nijmegen Medical Centre, Nijmegen; Canisius Wil- 
helmina Hospital, Nijmegen; Medical Centre Haaglan­
den, The Hague; Sint Maartens Hospital, Nijmegen. All 
Centres are located in the Netherlands. In all centres ethi­
cal approval is obtained.
Statistical analysis
The primary endpoint is clinical outcome after 1 year 
using the modified Japanese Orthopaedic Association 
functional score. Secondary outcomes are cost-effective­
ness, quality of life measured by the SF-36, and complica­
tions. Statistical analysis is performed by a blinded 
investigator. For Statistical analysis the SAS system is used. 
Descriptive statistics are used to describe baseline charac­
teristics. For comparison between groups student-t tests or 
chi -  square tests are used. Statistical significance is 
reached when p < 0.05. Risk ratios (RR) and 95 % confi­
dence limits (CI) are presented. All analyses are done 
according to the intention -  to -  treat principle
The minimal clinically important difference was esti­
mated by asking 4 international active spine surgeons 
what they would consider a clinically significant differ­
ence in mJOA score. The mean of the values is considered 
the MCID.
Table 2: overview  of investigations at each clinical contact
Preoperative Postoperative (po) 6 weeks po 3 months po l  year po
MRI X
Plain cervical radiograph X X X X X
mJOA X X X X
SF-36 X X X X
Neurologic examination by independent neurologist X X X
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The sample size is calculated as follows: a difference of at 
least two points on the modified JOA functional score is 
considered significant. The difference is expected to be 
mainly allocated to the function of the arms and legs. 
Based on literature, a standard deviation of approximately 
2 is assumed [12]. A two group student t test with a 0.05 
two sided significance level and a power of 95 % will need 
a sample size per group of 27 to detect a significant differ­
ence. Considering a ten percent of lost to follow up, a total 
of 30 individuals per group will be included.
Randomisation
For randomisation, the closed envelope method is used. 
As soon as informed consent is obtained, one of the treat­
ment options is assigned to the patient. The secretary of 
the neurosurgical department in the Canisius Wilhelmina 
Hospital, Nijmegen, the Netherlands will control the ran­
domisation. Prior to surgery, the patient is informed 
about the chosen option. Patients who do not choose for 
participation, are offered one of the surgical options that 
are currently under investigation. However, they are not 
followed in an observational cohort study.
Endpoints
Prim ary endpoints
Several score systems exist for grading the severity of cer­
vical myelopathy. The modified Japanese Orthopedic 
functional score (Fig. 2) evaluates four groups: the func­
tion of the arms, of the legs, the micturation, and the sen­
sibility of the hands. It has the major advantage that it 
assesses these functions separately [10]. Although it has 
been established that outcome after decompressive sur­
gery reaches a plateau at six months postoperatively [13], 
the primary endpoint will be evaluated at one year post­
operatively just to make sure.
Secondary endpoints
Since instrumentation is added in the fusion group, the 
costs will be higher. On the other hand, it is assumed that 
a mean better recovery will take place in the fusion group. 
Therefore, the additional costs (nursing costs, auxillary 
supports, etc.) may be lower. A careful evaluation of the 
costs of the treatment related to the outcome is per­
formed. To obtain a reliable insight in the costs the fol­
lowing will be noted in a kind of diary: hospitalisation, 
out -  patient contacts, additional medication, house 
keeping support, instruments to support daily activities, 
e.g. walking, eating etcetera. Of each item the sort and 
amount will be recorded.
Apart from the cost -  effectiveness, the difference in the 
general health status will be evaluated. It is assumed that 
general health will improve more after of a laminectomy 
with a fusion than one without. This will be reflected in a 
difference of the SF -  36 score. The Short Form 36 Health
I. Motor dysfunction score o f the upper extremities
Inability to move hands 0
Inability to eat with a spoon but able to move hands 1
Inability to button shirt but able to eat with a spoon 2
Able to button shirt with great difficulty 3
Able to button shirt with slight difficulty 4
No dysfunction 5
II. Motor dysfunction score o f the lower extremities
Complete loss of motor and sensory function 0
Sensory preservation without ability to move legs 1
Able to move legs but unable to walk 2
Able to walk on flat floor with a walking aid (i.e., cane or crutch) 3
Able to walk up and/or down stairs with hand rail 4
Moderate to significant lack of stability but able to 5 
walk up and/or down stairs without hand rail
Mild lack of stability but walk unaided with smooth reciprocation 6
No dysfunction 7
III. Sensation
Complete loss of hand sensation 0
Severe sensory loss or pain 1
Mild sensory loss 2
No sensory loss 3
IV. Sphincter dysfunction score
Inability to micturate voluntarily 0
Marked difficulty with micturition 1
Mild to moderate difficulty with micturition 2
Normal micturition 3
F ig u re 2
Modified Japanese Orthopaedic Association functional score.
Status Questionnaire is a widely-used generic health sta­
tus. This instrument consists of eight subscales and two 
summary scales. On each scale higher scores indicate bet­
ter outcomes. Scores can be compared with published age
-  and sex -  matched general population or disease-spe­
cific norms [14]. Furthermore, it has been validated for 
cervical spondylotic myelopathy [15].
Complications are separately registered. Complications 
related to the cervical myelopathy are postoperative hem­
orrhage, postoperative infection, temporary or permanent 
impairment of neurologic function, and kyphotic defor­
mation of the cervical spine[7]. Complications related to 
adding lateral mass screws or/and pedicle screws are ver­
tebral artery injury and temporary or permanent nerve 
root damage[7]. In order to prevent damage to the spinal
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cord, the instrumentation should be completed before the 
laminectomy.
M onitored events
Monitored events are the death of a patient, withdrawal 
from the study, lost to follow -  up, and cross -  over from 
their randomly assigned treatment group. These events are 
registered within the case record form. The circumstances 
of the events are investigated and also noted. In case of 
death of the patient, a search for a relationship with the 
instituted treatment is started. Throughout the study, all 
medical complications and intervening treatments con­
cerning the cervical spine are registered within the CRF at 
the usual follow -  up visits or when the appropriate infor­
mation reaches the treating surgeon.
Protocol violations
Any of the following will be considered as a deviation 
from the protocol: randomization of an ineligible patient, 
enrollment of a patient that is already participating in an 
another study, enrollment of an participant to this study 
in another study, a patient receiving the wrong treatment, 
loss of radiology or any other data, and informed consent 
violations. Violations are reviewed monthly and reported 
to the independent study supervisor (R.D. Donk, M.D., 
Canisius Wilhelmina Hospital, Nijmegen).
Subject confidentiality
The anonymity of the subjects will be maintained. Sub­
jects will be identified by their initials and a subject 
number assigned by the secretary of the neurosurgical 
department in the Canisius Wilhelmina Hospital, 
Nijmegen, the Netherlands. All CRFs and other docu­
ments submitted to the investigator will be assigned this 
code. The secretary will enter the data of the patient and 
their assigned code. This list is only accessible for the prin­
cipal investigator, and the independent supervisor.
Discussion
Movement as an cause additional to stenosis of cervical 
myelopathy has been recognised for longer time. A posi­
tive effect of fusion in addition to decompression by lam­
inectomy has been reported earlier. To our knowledge, the 
is the first randomised controlled trial comparing lami­
nectomy without and with dorsal instrumented fusion. 
Apart from the clinical effectiveness, a study is needed to 
explore the costeffectiveness of the treatments.
Several problems may arise. Randomization may be 
refused by some patients. However, experience from ear­
lier trials learned that after correct description of the pos­
sibilities and estimated outcomes patients will not be 
reluctant to be enrolled.
Through the age restriction, the results of the study cannot 
be generalized to the whole population. However, most 
often the patients with a symptomatic, degenerative, cer­
vical spinal canal stenosis will be 60 years old or older 
[16].
Since knowledge of the instrumentation and of biome­
chanics of the cervical spine is necessary to avoid compli­
cations and to optimise instrumented fusion only 
experienced spinal surgeons will collaborate with this 
study. This will prevent a discussion related to the pre­
sumed different skill levels of the surgeons in case of an 
unexpected result.
Finally, as a measure for the definitive clinical result the 
mJOA is chosen. This is the only scale that takes the ambu­
latory function, the function of the hands, the sensibility 
of the hands, and the micturation pattern separately into 
account. This scale is validated for the Japanese popula­
tion [17]. However, its English translation has never been 
validated. Now, the English mJOA has been translated 
into Dutch. The validation of this translation is currently 
under investigation.
Finally, Lamifuse tries to measure a difference in costs. 
Since most of the patient will not be working anymore but 
are retired, costs of material or personal support, extra 
medication etcetera will be calculated. These costs are spe­
cific for the Netherlands, and cannot be extrapolated to 
other countries.
Conclusion
Laminectomy for symptomatic cervical spinal stenisos is 
frequently performed. However, not only compressive 
forces are responsible for the complaints of the patient. 
Continuing motion of the spinal cord over anterior 
spondylophytic ridges is also believed to be a causative 
factor. Fusion will prevent motion. This randomised, con­
trolled study will compare the clinical results of laminec­
tomy without and with fusion for patients with a 
symptomatic stenosis of the cervical spinal canal. The 
design of Lamifuse is discussed as are its limitations.
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